Fraser Institute Proposes International Pharmaceutical Patent Reform

The Fraser Institute, a leading Canadian public policy think tank, has joined the chorus of voices asking to extend the life of Canadian pharmaceutical patents. Their report, released this month,…
Read More

Life Sciences Offer Women Ground-breaking Research Opportunities

STEM (Science, Technology, Engineering and Medicine) jobs are generally considered to be a vital part of the economy, and one of the hottest sectors for employment and education investment. As…
Read More

Top Canadian Pharmaceutical App Gets International Option

Last month, My MedRec went global. If you’re not familiar with the app, My MedRec is a free system designed on behalf of pharmaceutical industry representative association Rx&D. The iPhone…
Read More

Catastrophic Drug Plans to Span All Canadian Provinces

As of October, with the inclusion of New Brunswick, every Canadian province will have a catastrophic drug plan in place. These last resort measures protect families from medical bankruptcy and…
Read More

New Label Plan for Canadian Drugs

A new drug regulation was recently announced in Canada, this time controlling the packaging. That’s the Plain Language Labelling Initiative, which will be an overhaul of how drugs are described…
Read More

Pharmaceutical Quality Control and a Recent Recall

At the end of May, four companies announced a recall on five drugs commonly sold in Canada. The recall is not about a problem with the medications themselves, as a…
Read More

Rx&D Report Shows 34% Under Report Rate of Innovation Investment By Government Agencies

report by Rx&D, the Canadian association of pharmaceutical companies, confirms an ongoing trend of under-reporting of pharmaceutical innovation investment by government bodies. The report, released in May, shows a consistent…
Read More

Should Pharmaceutical Sales Professionals Educate Doctors About Drug Risks?

A recent study of 255 physicians in Canada, the United States and France highlights the important impact of pharmaceutical sales on doctors’ decisions and physicians’ reliance on sales representatives’ willingness…
Read More

Generics in Ontario

Last week we covered a generic drug pricing deal that will affect most of Canada. This week we’re coming back to Ontario to take a closer look at the local…
Read More

January’s Pan-Provincial Deal Means Price Cuts for Popular Generics

One of the current challenges in the pharmaceutical industry is the role of generic drugs. This January, several provinces and territories have joined together to put their combined weight to…
Read More